How Does Medicine Contribute To Pollution?

The presence of pharmaceuticals in the environment is a growing global concern. Pharmaceuticals are biologically active substances designed to cause pharmacological effects in living organisms, and when they enter the environment, they can have adverse effects on wildlife and ecosystems. Pharmaceuticals can be released into the environment through direct emissions from drug manufacturing, patient and animal excretion, aquafarming, and the disposal of unused or expired medicines. They can contaminate water, soil, and air, and their presence in freshwater ecosystems is of particular concern. The potential environmental impacts of the manufacture and use of medicines are only recently becoming a topic of research interest, and there are still significant knowledge gaps regarding the effects of pharmaceuticals on the environment and human health.

Pharmaceuticals in water

The presence of pharmaceuticals in water bodies and drinking water is a growing global concern. Pharmaceuticals enter water systems through multiple pathways, and their impact on the environment and human health is an emerging area of research.

Sources of Pharmaceuticals in Water

Pharmaceuticals can enter water systems through various sources, including:

• Manufacturing plants: Pharmaceutical manufacturing facility discharges contribute significantly to the pharmaceutical load in wastewaters. A US Geological Survey (USGS) study found that effluents from wastewater treatment plants (WWTPs) receiving discharge from pharmaceutical manufacturing facilities had 10 to 1,000 times higher concentrations of pharmaceuticals compared to WWTPs that did not receive such discharges.
• Human and animal excretion: Pharmaceuticals that are not fully metabolized by the body are excreted in urine, feces, or sweat, eventually making their way into wastewater. This includes both prescription and over-the-counter medications taken by humans, as well as drugs used in the livestock industry.
• Improper disposal: Consumers often dispose of unused or expired medications down the drain or toilet, contributing to pharmaceutical pollution in water systems. A German survey found that 43% of unused liquid medications were disposed of in this manner, while a British survey reported 12% of respondents disposed of unwanted pharmaceuticals down the drain.
• Health care institutions: Hospitals and nursing homes have been known to flush medications down the drain or toilet, particularly after a patient's discharge or death. Nursing homes, in particular, may lack proper arrangements for returning unused drugs to manufacturers.

Environmental and Health Impacts

The release of pharmaceuticals into the environment can have significant impacts on wildlife and ecosystem health:

• Adverse effects on aquatic life: Studies have shown that pharmaceuticals can have negative consequences for aquatic life, even though the impact on humans remains uncertain. There is evidence that chemical pollution from pharmaceuticals may be entering the food chain and altering the sex functions of fish.
• Persistence and bioaccumulation: Some pharmaceuticals are designed to be slowly degradable or non-degradable, allowing them to persist in the environment. These substances, known as environmentally persistent pharmaceutical pollutants (EPPPs), can adversely affect wildlife and cause long-term impacts on ecosystem health and resilience.
• Combination effects: Even if individual pharmaceutical contamination levels are low, the combination of multiple pharmaceuticals in water can potentially lead to negative health effects, especially if they interact with other substances consumed by humans or other organisms.

Addressing Pharmaceutical Pollution

To address the issue of pharmaceuticals in water, various measures can be implemented:

• Take-back programs: Programs that allow people to return unused medications to central locations help keep drugs out of the water and prevent their misuse.
• Improved disposal guidelines: Guidelines from the federal Environmental Protection Agency (EPA) discourage hospitals and nursing homes from flushing unused drugs, and provide recommendations for individuals as well.
• Wastewater treatment improvements: While challenging, there is a need to enhance wastewater treatment technologies to effectively remove pharmaceutical chemicals from water.
• Research and awareness: Initiatives like World Water Week and podcasts by organizations such as the USGS aim to raise awareness and promote further research on the issue of pharmaceuticals in water.

The impact of medicine on wildlife and ecosystems

Pharmaceuticals enter the environment through various pathways, including direct emissions from drug manufacturing, patient and animal excretion, aquafarming, and the disposal of unused or expired medication. Once released, they can contaminate air, water, soil, or sediment. Water-related ecosystems, in particular, are vulnerable to pharmaceutical pollution. Wastewater treatment plants are often unable to filter out chemical compounds used in drug manufacturing, leading to their release into freshwater systems and oceans. This has been observed in rivers and lakes, with over 101 different pharmaceuticals detected in ground, surface, drinking, or tap water in the United States, Spain, Germany, and the United Kingdom.

The presence of pharmaceuticals in the environment can have various effects on wildlife and ecosystems. For example, the excretion of oral contraceptives into freshwater ecosystems has been linked to the feminization of fish and amphibians. Antidepressants have been found in fish brains, altering their behavior and reducing their survival through predation. Antineoplastic drugs used in chemotherapy pollute watercourses and have mutagenic, cytostatic, and ecotoxicological effects on aquatic microorganisms. Additionally, the continuous release of medical products into the water cycle raises concerns about bioaccumulation and biomagnification.

Agricultural practices, such as the use of antibiotics in livestock, can also contribute to pharmaceutical pollution in the environment. When antibiotics are only partially metabolized, the non-metabolized portion is released into the environment, ending up in sludge, drinking water, wastewater, soil, and groundwater. This can result in soil contamination and the uptake of pharmaceuticals into food crops.

The role of drug manufacturing in pollution

The environmental impact of pharmaceuticals is not limited to water pollution. Pharmaceuticals can also be released into the air, soil, or sediment, with residues found in rivers, lakes, and groundwater aquifers. The breakdown and transportation of these compounds are influenced by various factors, including their physico-chemical properties and the characteristics of the receiving environment. For example, the sorption behaviour of a substance in soils and water systems can vary widely, affecting its distribution and persistence in the environment.

Direct emissions from drug manufacturing have been identified as a significant source of environmental pollution. Studies have shown that these emissions can result in the release of active pharmaceutical ingredients (APIs) into the environment, with potential toxic effects on non-target organisms and long-term impacts on ecosystem health and resilience. The discovery of oestrogens in sewage effluents, causing the feminization of fish, sparked increased interest in the environmental impact of pharmaceuticals. Additionally, the presence of pharmaceuticals in the environment can lead to the development of drug-resistant microorganisms, posing global health challenges.

While not all pharmaceutical manufacturing contributes to pollution, inadequate enforcement of environmental laws and regulations in certain regions, particularly in developing nations, has led to circumvention of protections. Initiatives such as the UN Environment Programme (UNEP) are working to address these issues by developing take-back programmes, promoting sustainable procurement practices, and raising awareness among stakeholders. Regulatory bodies, companies, and healthcare organizations also have a role to play in incentivizing and implementing pollution control measures during the drug manufacturing process.

The environmental risks of medicine disposal

Sources of Pharmaceutical Pollution

The sources of pharmaceutical pollution are varied and include direct emissions from drug manufacturing, patient and animal excretion, aquafarming, and the disposal of unused or expired medicine. It is important to note that wastewater treatment plants are often unable to remove chemical compounds, allowing them to seep into freshwater systems and oceans.

Environmental Impact

Once released into the environment, pharmaceuticals are transported and distributed through air, water, soil, or sediment. The degree of transportation between these media depends on the sorption behaviour of the substance and the characteristics of the receiving environment. For example, the half-life of the antiparasitic ivermectin is six times greater in winter conditions than in summer, and it degrades faster in sandy soils than in sandy loam soils.

Long-term Effects

Pharmaceuticals can have long-term effects on aquatic ecosystems even at low concentrations due to their bioactive and chemically stable nature. This can lead to recalcitrant behaviours in water, similar to those exhibited by persistent organic pollutants. The continuous release of medical products poses concerns about bioaccumulation and biomagnification, with evidence suggesting that chemical pollution may be entering the food chain and altering the sex functions of fish.

Global Concerns

Pharmaceutical pollution is a global issue, with a 2022 study finding that it threatens environmental and/or human health in more than a quarter of the studied locations. The problem is particularly acute in low- to middle-income countries with poor wastewater and waste management infrastructure. However, even in high-income countries, pharmaceuticals have been detected in ground, surface, drinking, and tap water.

Addressing the Issue

Addressing the environmental risks of medicine disposal requires a multifaceted approach. The United Nations Environment Programme (UNEP) is working on research and initiatives related to take-back programmes, environmentally sound disposal, sustainable procurement, and antimicrobial resistance. Additionally, the Swedish government has proposed a system that considers pollution control during manufacturing when awarding product subsidies.

The economic incentives for reducing medicine pollution

Economic incentives have been increasingly used to control pollution and improve environmental and health protection. Economic-incentive instruments have captured the attention of environmental policymakers due to their potential advantages over traditional command-and-control approaches. These incentives can be divided into five categories, with hundreds of applications across all levels of government.

Firstly, trading programs are cost-effective approaches where firms can either reduce emissions or purchase pollution "allowances" from other firms with lower emissions. An example is the U.S. Acid Rain Program, which successfully reduced sulfur dioxide emissions. Secondly, subsidies are financial incentives from the government for activities believed to be environmentally friendly. Examples include grants, low-interest loans, and favorable tax treatment. Thirdly, fees, charges, and taxes are widely used incentives to reduce the overall quantity of pollution. Fourth, deposit-refund systems are a type of tax-subsidy incentive where consumers pay a surcharge for polluting products and receive a rebate when properly disposing of or recycling them. Lastly, voluntary programs such as Energy Star and Waste Wise encourage polluting entities to go beyond mandated regulations.

Economic incentives are particularly useful for controlling unregulated pollution. For example, citizens can be incentivized to reduce waste through recycling and composting if there is a disposal charge based on waste volume. Similarly, fees for the disposal of industrial effluents in water treatment plants can reduce water pollution.

In the context of medicine pollution, economic incentives can be applied to reduce the release of pharmaceuticals into the environment. For instance, subsidies can be provided to pharmaceutical companies that implement sustainable practices and reduce chemical discharges into wastewater. Trading programs can also be utilized, where drug manufacturers purchase pollution allowances from companies with lower emissions. Fees and charges can be imposed on the disposal of unused or expired medications, encouraging proper disposal methods. Additionally, voluntary programs can promote the adoption of environmentally friendly practices within the pharmaceutical industry.

Frequently asked questions